首页> 美国卫生研究院文献>Pharmaceutics >Determination of Stable Co-Amorphous Drug–Drug Ratios from the Eutectic Behavior of Crystalline Physical Mixtures
【2h】

Determination of Stable Co-Amorphous Drug–Drug Ratios from the Eutectic Behavior of Crystalline Physical Mixtures

机译:从晶体物理混合物的共晶行为确定稳定的共非晶药物比

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Co-amorphous drug–drug systems have been developed with the overall aim of improving the physical stability of two or more amorphous drugs. Co-amorphous systems often show good physical stability, and higher solubility and dissolution rates compared to their crystalline counterparts. The aim of this study is to determine if eutectic mixtures of two drugs can form stable co-amorphous systems. Three drug–drug mixtures, indomethacin–naproxen (IND−NAP), nifedipine–paracetamol (NIF−PAR), and paracetamol–celecoxib (PAR−CCX), were investigated for their eutectic and co-amorphization behavior as well as their physical stability in the co-amorphous form. The phase diagrams of the crystalline mixtures and the thermal behavior of the co-amorphous systems were analyzed by differential scanning calorimetry. The solid-state form and physical stability of the co-amorphous systems were analyzed using X-ray powder diffractometry during storage at room temperature at dry conditions. Initial eutectic screening using nifedipine (NIF), paracetamol (PAR), and celecoxib (CCX) indicated that IND−NAP, NIF−PAR, and PAR−CCX can form eutectic mixtures. Phase diagrams were then constructed using theoretical and experimental values. These systems, at different drug-to-drug ratios, were melted and cooled to form binary mixtures. Most mixtures were found to be co-amorphous systems, as they were amorphous and exhibited a single glass transition temperature. The stability study of the co-amorphous systems indicated differences in their physical stability. Comparing the phase diagrams with the physical stability of the co-amorphous mixtures, it was evident that the respective drug–drug ratio that forms the eutectic point also forms the most stable co-amorphous system. The eutectic behavior of drug–drug systems can thus be used to predict drug ratios that form the most stable co-amorphous systems.
机译:共非晶药物系统已经被开发出来,其总体目标是改善两种或多种非晶药物的物理稳定性。与晶体相比,共非晶体系通常显示出良好的物理稳定性,较高的溶解度和溶解速率。这项研究的目的是确定两种药物的共晶混合物是否可以形成稳定的共非晶体系。研究了三种药物-药物混合物:消炎痛-萘普生(IND-NAP),硝苯地平-扑热息痛(NIF-PAR)和扑热息痛-塞来昔布(PAR-CCX)的共晶和共非晶行为以及物理稳定性以共非晶形式存在。通过差示扫描量热法分析了晶体混合物的相图和共非晶体系的热行为。在室温下于干燥条件下储存期间,使用X射线粉末衍射法分析了共非晶体系的固态形式和物理稳定性。使用硝苯地平(NIF),扑热息痛(PAR)和塞来昔布(CCX)进行的初始共晶筛选表明IND-NAP,NIF-PAR和PAR-CCX可以形成共晶混合物。然后使用理论值和实验值构建相图。将这些系统以不同的药物/药物比率熔融并冷却以形成二元混合物。发现大多数混合物是共非晶体系,因为它们是非晶态,并表现出单一的玻璃化转变温度。共非晶体系的稳定性研究表明其物理稳定性存在差异。将相图与共非晶混合物的物理稳定性进行比较,很明显,形成共晶点的相应药物/药物比率也形成了最稳定的共非晶体系。药物系统的共晶行为因此可以用来预测形成最稳定的共非晶系统的药物比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号